IDS-ISYS
LIVE

Serial Number

79406501

Owner

Immunodiagnostic Systems France SAS

Attorney

Kevan L. Morgan

Filing Date

Jun 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

IDS-ISYS Trademark

Serial Number: 79406501 • Registration: 7924152

IDS-ISYS is a trademark filed by Immunodiagnostic Systems France SAS on June 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Immunodiagnostic Systems France SAS

42 Rue Stéphane Mazeau

Entity Type: 34

Trademark Details

Filing Date

June 19, 2024

Registration Date

September 2, 2025

Published for Opposition

July 15, 2025

Goods & Services

Diagnostic preparations for medical and pharmaceutical purposes, in particular test kits comprising immunoassay cartridges, magnetic particles, microbeads, nanobeads and microspheres; diagnostic preparations for medical and veterinary purposes; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for the detection of allergies, neurological diseases, food intolerances, metabolic diseases, endocrine disorders, inflammation, infectious diseases, autoimmune diseases or cancers; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for the detection and measurement of drug and anti-drug antibodies, treatment and therapy efficiency monitoring, or monitoring or diagnosis or prognosis or prevention of diseases; diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for use as companion diagnostics; companion diagnostic agents for medical use; diagnostic agents for medical and veterinary purposes, in particular immobilized cells or viruses or components thereof, immobilized cell or tissue extracts or lysates, immobilized nucleic acids, immobilized proteins, immobilized polypeptides, immobilized peptides, immobilized antigens, immobilized allergens or immobilized antibodies on a carrier or a carrier material, in particular a microbead, nanobead, microsphere, magnetic particle, plastic or glass support; reagents for medical and veterinary diagnostic purposes; kits for in vitro diagnostic testing comprising immunoassay cartridges, magnetic particles, microbeads, nanobeads and microspheres for the detection of allergies, neurological diseases, food intolerances, metabolic diseases, endocrine disorders, inflammation, infectious diseases, autoimmune diseases or cancers; diagnostic test kits for medical and veterinary purposes, whereby the aforesaid goods comprise diagnostic agents for conducting tests on samples of biological origin, in particular blood, serum, plasma, cerebrospinal fluid, saliva, nasal swab, throat swab, faeces and urine; immunoserological test kits, comprising diagnostic agents for conducting immunoserological tests for medical purposes; quantitative immunoglobulin test kits comprising capture and detection agents, calibrator reagents and controls for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies for medical purposes; diagnostic test kits for medical and veterinary purposes, whereby the aforesaid goods comprise surface modified or surface activated microbeads, nanobeads or magnetic particles enabling the coupling of cells or viruses or components thereof, nucleic acids, proteins, polypeptides, peptides, antigens, allergens or antibodies.

Diagnostic preparations and diagnostic agents for scientific purposes and research use; diagnostic agents for scientific purposes and research use, in particular immobilized cells or viruses or components thereof, immobilized cell or tissue extracts or lysates, immobilized nucleic acids, immobilized proteins, immobilized polypeptides, immobilized peptides, immobilized antigens, immobilized allergens or immobilized antibodies on a carrier or a carrier material, in particular a microbead, nanobead, microsphere, magnetic particle, plastic or glass support; diagnostic test kits for scientific purposes and research use, whereby the aforementioned goods comprise monoclonal or polyclonal antibodies, antigens, allergens, proteins, polypeptides, peptides, nucleic acids, cells or viruses or components thereof, or cell or tissue extracts or lysates; diagnostic or research tests and test kits for scientific purposes and research use, whereby the aforementioned goods comprise diagnostic agents for the determination of the presence of a cell or virus or component thereof, nucleic acid, protein, polypeptide, peptide, antigen, allergen, hormone, steroid hormone, vitamin or antibody, in particular in a sample of biological origin, in particular blood, serum, plasma, cerebrospinal fluid, saliva, nasal swab, throat swab, faeces or urine.

Diagnostic instruments for medical use, namely, chemiluminescence instruments for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic, examination, and monitoring equipment, namely, chemiluminescence equipment for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic measuring apparatus for medical use, in particular namely, diagnostic chemiluminescence measuring apparatus for measuring levels of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; medical diagnostic apparatus for medical purposes, namely, chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; medical diagnostic testing instruments for use in immunoassay procedure, namely, chemiluminescence testing instruments for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic apparatus for medical purposes used in medical laboratories, namely, diagnostic chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for medical purposes used in medical laboratories

Scientific instruments for diagnosis, namely, chemiluminescence diagnostic apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens; diagnostic apparatus not for medical purposes, namely, chemiluminescence diagnostic apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, not for medical purposes; diagnostic apparatus for research laboratory use, namely, chemiluminescence apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for research laboratory use; testing apparatus for diagnostic purposes, namely, chemiluminescence testing apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, for diagnostic purposes; measuring apparatus not for medical purposes, namely, chemiluminscence measuring apparatus for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens, not for medical purposes; laboratory instruments, in particular chemiluminscence measurement laboratory instruments; downloadable software, in particular laboratory software for detecting the presence of immunoglobulin A (IgA), IgG, IgM or IgE antibodies, proteins, and antigens

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 9, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 26, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 19, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 2, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 2, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 2, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 1, 2025 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2025 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Feb 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 2, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 15, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2024 REPR